NYSE - Nasdaq Real Time Price USD

West Pharmaceutical Services, Inc. (WST)

369.98 +1.80 (+0.49%)
As of 9:43 AM EDT. Market Open.
Loading Chart for WST
DELL
  • Previous Close 368.18
  • Open 384.48
  • Bid 362.27 x 800
  • Ask 370.00 x 800
  • Day's Range 362.06 - 370.00
  • 52 Week Range 310.42 - 415.73
  • Volume 15,032
  • Avg. Volume 544,422
  • Market Cap (intraday) 27.085B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 48.81
  • EPS (TTM) 7.58
  • Earnings Date Jul 25, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 0.80 (0.22%)
  • Ex-Dividend Date Jul 31, 2024
  • 1y Target Est 403.29

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

www.westpharma.com

10,600

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WST

Performance Overview: WST

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WST
5.18%
S&P 500
6.61%

1-Year Return

WST
3.86%
S&P 500
24.89%

3-Year Return

WST
15.07%
S&P 500
21.65%

5-Year Return

WST
206.67%
S&P 500
73.78%

Compare To: WST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WST

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    26.82B

  • Enterprise Value

    26.52B

  • Trailing P/E

    48.57

  • Forward P/E

    48.31

  • PEG Ratio (5yr expected)

    6.52

  • Price/Sales (ttm)

    9.42

  • Price/Book (mrq)

    10.00

  • Enterprise Value/Revenue

    8.99

  • Enterprise Value/EBITDA

    31.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.42%

  • Return on Assets (ttm)

    11.57%

  • Return on Equity (ttm)

    20.84%

  • Revenue (ttm)

    2.93B

  • Net Income Avi to Common (ttm)

    568.7M

  • Diluted EPS (ttm)

    7.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    601.8M

  • Total Debt/Equity (mrq)

    11.44%

  • Levered Free Cash Flow (ttm)

    152.9M

Research Analysis: WST

Analyst Price Targets

355.00
403.29 Average
369.98 Current
470.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: WST

Fair Value

369.98 Current
 

Dividend Score

0 Low
WST
Sector Avg.
100 High
 

Hiring Score

0 Low
WST
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
WST
Sector Avg.
100 High
 

Research Reports: WST

  • WST: Raising target price to $410.00

    WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $410.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • WST: Lowering target price to $398.00

    WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $398.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • WST: Raising target price to $412.00

    WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $412.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • WST: Lowering target price to $407.00

    WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $407.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch